|Articles|December 1, 2007

Report from the Roundtable: Progress and Opportunities in the Managed Care of Dementia
Volume 13
Issue 8 Suppl

Current Issues in Dementia Pharmacotherapy

Author(s)Lori A. Daiello, PharmD, BCPP, FASCP

Download PDF: Current Issues in Dementia Pharmacotherapy

Articles in this issue

over 18 years ago

Article

Participating Faculty

over 18 years ago

Article

Introduction

over 18 years ago

Article

The Burden of Dementia

over 18 years ago

Article

Current Implications for the Managed Care of Dementia

over 18 years ago

Article

Frequently Asked Questions and Answers for Long-term Care Healthcare Professionals

over 18 years ago

Article

CME/CE Posttest

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

Current Issues in Dementia Pharmacotherapy

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

COVID Is Back in the Bay Area: Is It the XFG "Stratus" Variant?

Zanubrutinib Outlasting Acalabrutinib in CLL

What Comes After Anti-VEGF in Wet AMD: Arshad Khanani, MD

FDA Clears Lerodalcibep-Liga Autoinjector, Widens LDL-C Indication

Experts Weigh Vitiligo's Cosmetic Label as Oral Therapies Near